Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

被引：0
|
作者：
David M. G. Halpin
Marjan Kerkhof
Joan B. Soriano
Helga Mikkelsen
David B. Price
机构：
[1] Royal Devon & Exeter Hospital,Department of Respiratory Medicine
[2] Research in Real-Life Ltd,Instituto de Investigación Hospital Universitario de la Princesa (IISP)
[3] Universidad Autónoma de Madrid,Academic Primary Care, Division of Applied Health Sciences
[4] Cátedra UAM-Linde,undefined
[5] Cambridge Research Support Ltd,undefined
[6] University of Aberdeen,undefined
来源：
Respiratory Research | / 17卷
关键词：
Randomised controlled trial; Real-life research; Chronic obstructive pulmonary disease; Long-acting bronchodilator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study
    Jahnz-Rozyk, Karina
    Szepiel, Pawel
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 613 - 623
  • [32] Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study
    Voduc, Nha
    Alvarez, Gonzalo G.
    Amjadi, Kayvan
    Tessier, Caroline
    Sabri, Elham
    Aaron, Shawn D.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 245 - 252
  • [33] Nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD.
    Baumgartner, Rudolf A.
    Hanrahan, John P.
    Sciarappa, Kenneth
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A95 - A95
  • [34] Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
    Wurst, Keele E.
    St Laurent, Samantha
    Mullerova, Hana
    Davis, Kourtney J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 1021 - 1031
  • [35] Factors Associated With Adherence To Long-Acting Inhaled Therapies Among Patients With COPD
    Cecere, L. M.
    Slatore, C. G.
    Uman, J.
    Evans, L.
    Udris, E. M.
    Bryson, C. L.
    Au, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [36] Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators
    Mapel, Douglas
    Schum, Michael
    Yood, Marianne
    Brown, Jeffrey
    Miller, David
    Davis, Kourtney
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 109 - 117
  • [37] Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists
    Mapel, DW
    Hurley, JS
    Roblin, D
    Roberts, M
    Davis, KJ
    Schreiner, R
    Frost, FJ
    RESPIRATORY MEDICINE, 2006, 100 (04) : 595 - 609
  • [38] INDACATEROL/GLYCOPYRRONIUM VS SINGLE LONG-ACTING MUSCARINIC ANTAGONIST IN LONG-ACTING BRONCHODILATOR-NAIVE COPD PATIENTS: POOLED ANALYSIS
    Kostikas, K.
    Muro, S.
    Yoshisue, H.
    Olsson, P.
    Gupta, P.
    Wedzicha, J.
    RESPIROLOGY, 2019, 24 : 50 - 50
  • [39] Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD
    Cazzola, M
    Dahl, R
    CHEST, 2004, 126 (01) : 220 - 237
  • [40] Prevalence of COPD, Disease Severity, and Symptoms in Subjects on Long-Acting Bronchodilator Monotherapy for COPD
    Crater, G.
    Yawn, B.
    Bailey, W. C.
    Dransfield, M. T.
    Emmett, A.
    O'Dell, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345